Vera Therapeutics CEO sells shares worth over $821k By Investing.com

Vera Therapeutics CEO sells shares worth over $821k By Investing.com

BRISBANE, Calif. — Fordyce Marshall, president and CEO of Vera Therapeutics Inc. (NASDAQ:VERA), recently completed a series of stock transactions, according to a filing with the Securities and Exchange Commission. On December 11th, Marshall sold 17,500 shares of Class A common stock, netting approximately $821,523. Shares were traded at prices ranging from $46.9112 to $47.65. … Read more

Donegal group sr. vice president sells $250k in stock By Investing.com

Donegal group sr. vice president sells $250k in stock By Investing.com

William Albert Folmar, senior vice president of Donegal Group Inc. (NASDAQ: ), announced a significant transaction involving the company’s Class A common stock. On December 6, 2024, Folmar exercised options to purchase 15,000 shares at $15.80 each, for a total of approximately $237,000. He subsequently sold the same number of shares at $16,672 per share, … Read more